Generic Orthopedic Implants Time has Come (MedCrave)
Read ALL Generic articles
The U.S. orthopaedic implant industry is a $20 to $25 billion business and amazingly, almost 75% of these time-tested (stable) technologies have expiring patents. This typically means it is no longer necessary to continue to pay a premium for these products. In most other industries, as technologies become stable, they become a value proposition and thus, price declines over time. My biggest fear in buying an iPhone is that a better (and cheaper) one is going to be released next month. There are a few areas in medic...
